As of April 16, 2025, Galmed Pharmaceuticals (GLMD) has a market cap of $2.958 million USD. According to our data, Galmed Pharmaceuticals is ranked No.9109 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $2.96 M |
-44.04%
|
Dec 31, 2024 | $5.29 M |
-41.58%
|
Dec 29, 2023 | $9.05 M |
-9.00%
|
Dec 30, 2022 | $9.94 M |
-72.53%
|
Dec 31, 2021 | $36.19 M |
-41.48%
|
Dec 31, 2020 | $61.84 M |
-46.19%
|
Dec 31, 2019 | $0.11 B |
-15.37%
|
Dec 31, 2018 | $0.14 B |
-25.36%
|
Dec 29, 2017 | $0.18 B |
160.68%
|
Dec 30, 2016 | $69.79 M |
-53.88%
|
Dec 31, 2015 | $0.15 B |
31.21%
|
Dec 31, 2014 | $0.12 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Madrigal Pharmaceuticals
MDGL
|
$6.77 B |
-0.000 M
|
![]() USA
|
![]() Genfit
GNFT
|
$0.18 B |
-0.000 M
|
![]() France
|
![]() Viking Therapeutics
VKTX
|
$2.59 B |
0.000 M
|
![]() USA
|
![]() Akero Therapeutics
AKRO
|
$2.94 B |
0.000 M
|
![]() USA
|
![]() 89bio
ETNB
|
$0.86 B |
-0.000 M
|
![]() USA
|
![]() Hepion Pharmaceuticals
HEPA
|
$4.06 M |
0.000 M
|
![]() USA
|
![]() Terns Pharmaceuticals
TERN
|
$0.20 B |
-0.000 M
|
![]() USA
|
![]() Galectin Therapeutics
GALT
|
$84.66 M |
0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.93 B |
0.001 M
|
![]() USA
|
Market Cap | = | GLMD Stock Price | * | GLMD Shares Outstanding |
= | $1.31 | * | 2.26 M | |
= | $2.96 M |